Skip to main content

Effects of deworming medication on anaemia among children aged 6–59 months in sub-Saharan Africa

Abstract

Background

Despite the limited knowledge regarding the effects of deworming medication (DM) on nutritional indicators in sub-Saharan Africa (SSA), deworming programmes continue to be implemented in resource-limited countries. Therefore, the current study aimed to examine the effects of DM on anaemia among children aged 6–59 months in SSA.

Methods

The analysis was performed using data obtained from 17 demographic and health surveys (DHSs) conducted in SSA. Children were considered to be anaemic if their haemoglobin (Hb) concentration was less than 11.0 g/dl, adjusting for altitude. To account for both multiple measures at the cluster level and the clustering of children within the same country, generalized linear mixed models were used to analyse the anaemia outcomes in 50,075 children aged 6–59 months.

Results

Overall, anaemia was reported in 61.8% of the children, and their median Hb concentration was 10.5 g/dl (interquartile range 9.4–11.5). The prevalence of anaemia ranged from 34.5% in Rwanda to 81.1% in Mali. Multivariate analyses showed that children who did not receive DM had increased odds of being anaemic (adjusted odds ratio [aOR]: 1.11; 95% confidence interval [CI] 1.07–1.16).

Conclusions

The current study revealed that DM can decrease the risk of anaemia among preschool-age children (pre-SAC) in SSA. Thus, tailored public health programmes aimed at reducing childhood anaemia need to consider deworming. However, longitudinal studies are needed to validate the association that has been reported in this cross-sectional study.

Graphical Abstract

Background

Globally, soil-transmitted helminth (STH) infections are the most common neglected tropical diseases (NTDs), affecting more than 1.5 billion people, or 24% of the world’s population [1]. Generally, STH infections are broadly distributed in tropical and subtropical parts of the world, with the greatest numbers occurring in sub-Saharan Africa (SSA), the Americas, China, and East Asia. Nonetheless, the highest burden occurs in SSA [1, 2]. STH infections are transmitted from person to person through soil contaminated by human faeces [2]. They affect children living in poverty, usually in an environment that lacks adequate sanitation [3]. The World Health Organization (WHO) reported that approximately 270 million preschool-age children (pre-SAC) reside in settings where these parasites are transmitted [1, 4].

The main species of STHs that affect people include roundworms (Ascaris lumbricoides), whipworms (Trichuris trichiura), and hookworms (Necator americanus and Ancylostoma duodenale) [2]. However, all these species are placed under the same group since they share similar diagnostic protocols and quite often respond to the same chemotherapy [1, 2]. Commonly, a single dose of albendazole (400 mg) or mebendazole (500 mg) administered annually or biannually is used for deworming [5]. WHO recommends deworming medication (DM) as a public health strategy for all pre-SAC residing in settings where the baseline prevalence of any STH is 20% or more, in order to reduce the burden of STHs [5, 6].

The WHO 2012 NTD roadmap target aimed at treating at least 75% of pre-SAC where the prevalence in this age group surpassed 20% [7, 8] and 75% coverage with preventive chemotherapy (PC) achieved in pre-SAC in 100% of countries by 2020 [8, 9]. However, because numerous countries were on the verge of achieving this goal, a revised 2020 NTD roadmap with new goals for eliminating STHs as a public health problem by 2030 was proposed [10]. Generally, WHO defines elimination of a public health problem as less than 2% moderate to heavy infections of STHs [11]. Thus, achieving these goals requires both mass distribution of DM and monitoring of prevalence over time. STH infections are a major public health hazard not only because they disturb an individual’s physical development and lead to cognitive and educational deficits, but also because they interfere with nutritional uptake and digestion [3, 12]. Specifically, hookworms may impair the nutritional status of the individuals by feeding on the host tissues, including host blood, which leads to a loss of iron and protein [13]. Furthermore, worms increase malabsorption of nutrients, and may likely compete for vitamin A in the intestine, as well as causing diarrhoea and dysentery [14, 15]. Additionally, STHs, and hookworms in particular, may induce chronic intestinal blood loss that can result in anaemia [1].

Anaemia is a condition in which haemoglobin (Hb) concentration and/or amount of red blood cells (RBCs) are inadequate to meet an individual’s oxygen-carrying capacity [16, 17]. Globally, anaemia is a major global public health hazard that predominantly affects young children [18]. WHO estimates indicate that 42% of pre-SAC worldwide are anaemic [19]. Even though it is well established that iron deficiency is the most important etiology of anaemia, other conditions such as malaria, parasitic infection, nutritional deficiencies, and haemoglobinopathies [21,22,23,24,25] also can all increase the risk of anaemia. Consequently, anaemia may eventually lead to poor developmental growth in children, which has long-term implications such as poor cognitive capacity and poor human capital. Given that human capital is an important input for economic growth, as it provides the necessary labour, anaemia may thus have a direct effect on economic growth and development [20, 21].

Numerous studies have reported the positive association between intestinal parasitic infections and various nutritional outcomes including anaemia among young children [22,23,24,25], yet the influence of deworming and its impact on nutritional outcomes have drawn mixed reactions [2, 26,27,28]. Nonetheless, the implementation of DM and its effects on anaemia among pre-SAC has been inconsistent and problematic. WHO uses the school setting as an ideal platform for public health interventions in many types of health care, including health education, iron supplementation, and DM for parasitic infections [29]. As a result, pre-SAC are less likely to benefit from such programmes, as they are in communities where such programmes are rarely implemented. Accordingly, the principal aim of this study was to examine the effects of DM on anaemia among children aged 6–59 months in SSA. Further, the secondary aim of this study was to examine the coverage and factors associated with DM in pre-SAC. The results of this study will be useful in assessing whether African countries are on track to achieving the African Agenda 2063 aspiration 6 [30] and Sustainable Development Goals (SDGs) 2 and 6 [31], and whether the WHO 2030 elimination goals for STH will be met.

Methods

Study design

The current study used secondary data from the 17 demographic and health surveys (DHSs) conducted in SSA. These surveys are comparable and representative (at the national level, residence level, and regional level) cluster-sample household surveys that have been conducted in more than 90 countries globally since 1984 [32]. Details about these surveys can be accessed elsewhere [33].

Data sources

We pooled 17 DHSs conducted between 2014 and 2018 in SSA. Specifically, the following countries were included: Benin (2018), Burundi (2018), Cameroon (2018), Ethiopia (2016), Ghana (2017), Guinea (2018), Lesotho (2014), Mali (2018), Malawi (2016), Nigeria (2018), Rwanda (2015), Sierra Leone (2019), South Africa (2016), Tanzania (2016), Uganda (2016), Zambia (2018), and Zimbabwe (2015) [33]. Figure 1 shows the selected SSA countries included in this study. Generally, these countries were selected and included because they had information on both DM and Hb estimates.

Fig. 1
figure 1

(Source: QGIS version 3.16)

Sub-Saharan African countries selected based on the availability of data

Data collection

In the DHS, information was collected from women aged 15–49 years with under-5 children prior to the survey using the Woman’s Questionnaire. Data on immunization coverage, DM, iron supplementation, vitamin A supplementation, anthropometric measurements and nutritional indicators, recent occurrences of diarrhoea, fever, and cough for young children, and treatment of childhood diseases were collected.

Inclusion and exclusion

We focused on pre-SAC because the DHS collects data on that age group and not on school-age children (SAC). We limited our analyses to live children aged 6–59 months as per WHO recommendation. Furthermore, children whose households were not selected for height and weight measurements or who had missing data on the other variables were excluded. This study included children whose caregivers had been interviewed and had provided consent. After applying the inclusion and exclusion criteria, which included age restriction, 50,075 children under 5 years of age were included in the analysis (Fig. 2).

Fig. 2
figure 2

Inclusion and exclusion criteria of the study participants

Anaemia testing

In each country, anaemia testing was performed in the subsample of selected households. Blood samples for anaemia testing were collected from all children aged 6–59 months for whom consent was obtained from their parents or the adult responsible for the children. Blood samples were drawn from a drop of blood taken from a finger prick (or a heel prick from children aged 6–11 months) and collected in a microcuvette. Analysis of Hb was conducted on-site with a battery-operated portable HemoCue analyser.

Anthropometric measurements

All the DHS surveys included in this study, height, and weight were collected from children under the age of 5 years who resided in the household the previous night prior to the data collection [34]. Weight measurements of the children were collected using electronic SECA 878 flat scales while ShorrBoard® measuring boards were used to record the height measurements. For children less than 24 months old, recumbent height/length measurements were taken, while standing height/length measurements were recorded for children aged 24 months or older [35]. Information on age, height, and weight was used to calculate several childhood nutritional indices (height/length for age, weight for height/length, and weight for age).

Operationalization of the study variables

Outcome variable

The principal outcome variable of this study was anaemia (as measured by Hb). WHO recommendations were used to define anaemia in children aged 6–59 months. Children were considered to be anaemic if their Hb concentration was less than 11.0 g/dl, adjusting for altitude [36].

Main explanatory variable

The principal explanatory variable of the current study was DM. Caregivers were asked, “Was (NAME) given any drug for intestinal worms (deworming chemotherapy) in the last 6 months?” The answer to this question was categorized as “yes” if the child had received DM and “no” if the child had not received DM.

Potential confounders

Based on insights from relevant literature [37], the following characteristics were treated as potential confounders: child-level factors included sex of the child (male/female), age of the child in months (6–11, 12–23, 24–35, 36–47, and 48–59), presumed fever in the last 2 weeks (no/yes), and an episode of diarrhoea in the last 2 weeks (no/yes). An episode of diarrhoea was defined as the passage of three or more loose or liquid stools in 24 h [38]. We also considered variables that measure the nutritional status of the child, including stunting status (not stunted/stunted) and wasting status (not wasted/wasted). In addition, we considered factors at the maternal and household levels, and these characteristics included the age of the respondents in years (< 25, 25–34, ≥ 35), maternal anaemia (no/yes), education level of the respondents (no formal education, primary education, and secondary and above education), household wealth (poorest, poorer, middle, richer, and richest), amount of media exposure (0, 1, 2, and 3), type of drinking water sources (unimproved/improved), type of household sanitation facility (unimproved/improved), place of residence (urban/rural), and year of the data collection (2014, 2015, 2016, 2017, 2018, and 2019). Childhood stunting and wasting were defined as moderate and severe—that is, below minus two standard deviations (< −2SD) from median height-for-age and weight-for-age z-scores of the reference population, respectively [39].

Further, the observations for the household sources of drinking water and type of toilet facility were classified as “improved” and “unimproved” using the revised definitions specified by the WHO/UNICEF Joint Monitoring Programme (JMP) report [40]. Improved water sources included piped water into dwelling, piped water to yard/plot, public tap or standpipe, tube well or borehole, protected dug well, protected spring, and rainwater, while unimproved water sources included unprotected dug well, and unprotected spring, river, dam, lake, pond, stream, canal, and irrigation canal [40]. Improved sanitation facilities included flush toilet, piped sewer system, septic tank, flush/pour flush to pit latrine, ventilated improved pit latrine, pit latrine with slab, and composting toilet. Unimproved sanitation facilities included pit latrines without a slab or platform, hanging latrines or bucket latrines, and open defecation [40].

Maternal anaemia was defined as mothers with Hb levels of less than 12.0 g/dl, adjusting for altitude [36]. The amount of media exposure was derived from the following questions: (i) Do you read a newspaper or magazine at least once a week, less than once a week, or not at all? (ii) Do you listen to the radio at least once a week, less than once a week, or not at all? (iii) Do you watch television at least once a week, less than once a week, or not at all? Then, the amount of media exposure was calculated by summing up the reported frequency of each media if an activity was performed at least once a week. The household wealth index was constructed using data on a household’s ownership of selected assets, such as televisions and materials used for constructing the house, using the DHS wealth index [41].

Statistical analyses

Firstly, descriptive analyses were performed and are reported as frequency and percentage with their 95% confidence intervals (CI). To calculate unbiased estimates, the sampling weight, strata, and cluster were incorporated. Secondly, bivariate analyses were conducted using Rao–Scott Chi-square to test the differences between children who did and did not receive DM. Thirdly, multivariate logistic analyses were constructed using generalized linear mixed models with the binomial distribution and the logit link function, since children from the same communities/neighbourhoods/countries may present characteristics that are similar to those of individuals from different communities/countries. Thus, we adjusted for the correlated individual responses nested under a single country using models that handle correlated responses. We reported adjusted odds ratios (aORs) with their P-values and 95% CI. We also incorporated survey year fixed effects that control for common time effects across all surveys. We employed multivariable logistic regression to examine the independent factors associated with DM. A significance level of alpha equal to 5% was used to determine the statistical significance. All data entry, cleaning, and statistical analyses were conducted using SAS version 9.4 software (SAS Institute, Cary, NC, USA). We focused on only two levels (i.e. children as level 1 and country as level 2), since we were interested in examining the effects of DM on anaemia among children aged 6–59 months in selected SSA countries; multilevel models with dichotomous outcomes were employed to estimate the odds of success and the impact of various characteristics at different levels.

$$Y_{ij} = \beta_{0j} + \beta_{1j} X_{ij} .$$
(1)

Equation (1) presented above indicates a simple level 1 model with one child-level predictor, where Yij signifies the anaemia status for child i in country j, β0j signifies the intercept or the average log odds of the occurrence of anaemia in the country j, Xij is a level 1 predictor for a child i in country j, and β1j indicates the slope associated with Xij showing the link between the child-level variables and the log odds of anaemia occurrence. The regression coefficients are modelled hierarchically as follows:

$$\beta_{0j} = \gamma 00 + \gamma 01W_{j} + U_{0j} ,$$
(2)
$$\beta_{1j = } \gamma 10.$$

Equation 2 shows a simple level 2 model with one child-level predictor, where γ00 provides the log odds of anaemia prevalence among all counties, Wj is a country-level predictor, γ01 is the slope associated with this predictor, U0j is the level 2 error term representing the unique effect associated with country j, and γ10 is the average effect of the child-level predictor. Therefore, an integration of the level 1 and level 2 models produces the following.

$$Y_{ij} = \, \gamma 00 + \gamma 10X_{ij} + \gamma 01W_{j} + U_{0j} .$$
(3)

Results

Characteristics of the study participants

Table 1 presents the characteristics of the study participants. Overall, a total of 50,075 pre-SAC aged 6–59 months were extracted from 17 SSA countries and analysed in this study. Approximately half of the respondents (49%) were distributed in the age group 25–34 years, and a quarter (25%) had secondary and above education. Additionally, about 2% of the respondents had access to all three forms of mass media (newspaper, radio, and television). With regards to household environmental factors, about two-thirds of respondents (64%) had access to an improved water source, less than half (43%) had improved sanitation facilities, and over three-quarters of the respondents were rural dwellers.

Table 1 Characteristics of the study participants in 17 SSA countries, 2014–2019

Prevalence of anaemia and other health-related characteristics

Figure 3 shows the results of the prevalence of anaemia in surveyed pre-SAC, where 61.7% (95% CI 61.2–62.2) of the pre-SAC were anaemic. The prevalence of anaemia was highest in Mali (81.1%) and lowest in Rwanda (34.5%). However, the median concentration of Hb was higher among pre-SAC that received DM compared to pre-SAC that did not receive DM, as shown in Fig. 4. Overall, the coverage of DM in SSA was reported at 42.5% (95% CI 41.9–43.0), as presented in Fig. 5. The coverage was highest in Rwanda (81.0%) and lowest in Ethiopia (13.7%). Regarding child health-related outcomes, about 15% and 23% of children had experienced fever and diarrhoea episodes in the prior 2 weeks, respectively. Approximately 38% of children were stunted and 5% of children were wasted.

Fig. 3
figure 3

The prevalence of anaemia stratified by countries

Fig. 4
figure 4

The median haemoglobin concentration among pre-SAC stratified by deworming medicine

Fig. 5
figure 5

The coverage of deworming medication stratified by countries

Prevalence of anaemia in children aged 6–59 months by selected characteristics

Table 2 presents the prevalence of anaemia among children aged 6–59 months by selected factors. The prevalence was significantly different with respect to DM status (χ2 = 165.73, df = 1, P < .0001), child age (χ2 = 2138.61, df = 4, P < .0001), sex of the child χ2 = 38.16, df = 1, P < .0001), history of reported fever (χ2 = 409.64, df = 1, P < .0001) and diarrhoea (χ2 = 167.47, df = 1, P < .0001) in the last 2 weeks, nutritional status of the child-stunting (χ2 = 356.99, df = 1, P < .0001) and wasting (χ2 = 118.46, df = 1, P < .0001), age of the respondents (χ2 = 108.83, df = 2, P < .0001), education level of the respondents (χ2 = 916.52, df = 2, P < .0001), Hb level of the respondents (χ2 = 1629.21, df = 1, P < .0001), household wealth (χ2 = 597.71, df = 4, P < .0001), types of water sources (χ2 = 72.86, df = 1, P < .0001), sanitation facilities (χ2 = 213.69, df = 1, P < .0001), place of residence (χ2 = 115.50, df = 1, P < .0001), and year of the survey (χ2 = 1138.47, df = 5, P = 0.001).

Table 2 Association of deworming medicine and other risk factors with anaemia in children aged 6–59 months in 17 SSA countries, 2014–2019

The effect of DM on anaemia in children aged 6–59 months

Table 2 also shows the effects of DM on anaemia. Children who did not receive DM were 1.1 times as likely (aOR: 1.11; 95% CI 1.07–1.16; P < .0001) to be anaemic as their counterparts.

Factors associated with coverage of DM among children aged 6–59 months

Table 3 shows factors associated with a recipient of DM among pre-SAC. Children of age group 6–11 months were 77% (aOR: 0.23; 95% CI 0.21–0.24; P < .0001) less likely to receive DM compared to children of age group 48–59 months. Compared to children whose respondents were 35 years and above, children whose respondents were 25 years and less were 21% (aOR: 0.79; 95% CI 0.74–0.84; P < .0001) less likely to receive DM. Furthermore, children from the poorest households and whose respondents had no formal education were 51% (aOR: 0.49; 95% CI 45–0.53; P < .0001) and 52% (aOR: 0.48; 95% CI 45–0.51; P < .0001) less likely to receive DM compared to their richest counterparts and whose respondents had secondary education and above, respectively. Additionally, children whose households had no media exposure were 45% (aOR: 0.55; 95% CI 0.48–0.64; P < .0001) less likely to receive DM than those from households that had access to all three modes of media (newspaper, radio, and television). Conversely, children from urban areas were 20% (aOR 0.80: 95% CI 0.75–0.85; P < .0001) less likely to receive DM compared to their rural counterparts.

Table 3 Factors associated with coverage of deworming medicine in children aged 6–59 months, 17 SSA, 2014–2019

Discussion

We aimed to examine the effects of DM on anaemia among pre-SAC in selected countries in SSA. The finding on the high prevalence of anaemia is consistent with what was reported by the World Bank [42]. The principal strategies that have been used to control anaemia over the past decades are iron supplementation and food fortification [43, 44]. However, public health programmes that target a large population such as DM have received little attention among pre-SAC. And yet there is empirical evidence on the high prevalence of anaemia attributable to intestinal parasite infection among older children in developing countries.

The most important finding of this study was that children who did not receive DM were more likely to be anaemic. Many previous studies have reported that children who had STHs were more likely to have micronutrient deficiency [45,46,47]. For example, a study on species-specific STHs and micronutrients (Hb, plasma ferritin, retinol, zinc, and urinary iodine) in Vietnamese SAC found that Ascaris infections exhibited a negative association with vitamin A, while Trichuris and hookworm infections were associated with lower Hb levels. Furthermore, children who were infected with Trichuris were more likely to have zinc deficiency than uninfected children [48].

In Nigeria, a study on STHs and anaemia status of children reported that hookworm and Ascaris lumbricoides infections were associated with anaemia. However, it was reported that serum ferritin levels were more sensitive than Hb in detecting anaemia and were correlated with intestinal helminth infection [49]. Thus, STH control in pre-SAC through deworming may contribute to lowering the burden of anaemia as well as increasing Hb levels in pre-SAC. For example, a meta-analysis of eight studies found a significant change in the Hb levels after deworming, and the prevalence of anaemia decreased markedly after the DM programme [29].

It is reported that deworming prevents hookworm infection, which is one of the major causes of iron loss in children, and in turn prevents anaemia [29]. Previously it was suggested that STH infections may cause malabsorption of both macro- and micronutrients. which in turn can interfere with iron metabolism and result in undernutrition, including anaemia, among young children [50]. Typically, Necator americanus and Ancylostoma duodenale adhere to and feed from the intestinal mucosa, thus causing blood (and iron, protein) loss and, depending on underlying iron status as well as the presence of other risk factors, possibly leading to iron-deficiency anaemia [13]. Furthermore, worms may compete for vitamin A in the intestine and may induce chronic intestinal blood loss that can result in anaemia [14, 15, 51, 52]. Previous researchers reported that low Hb concentration owing to hookworm infection was the largest cause of anaemia in Oceania and East Asia [53]. Elsewhere, hookworm infections were reported to be less prevalent among pre-SAC, and it was suggested that hookworms may not have significant effects on anaemia among this vulnerable group [16]. However, in Malawi, children with hookworm infections were reported to be severely anaemic [22].

We also examined the factors associated with DM coverage and found that young children were less likely to receive DM. To date, no study has ever addressed why young children have a reduced chance of receiving DM. However, many DM programmes in SSA utilize school settings, typically because SAC are thought to be a group with the highest intensity of worm infection [54]. Additionally, it has been proven that school-based targeted deworming programmes provide an opportunity for STH control efforts while utilizing an existing school-based infrastructure to reach a large proportion of SAC, with teachers acting as drug distributors [55]. Moreover, research has demonstrated that when older children are treated with DM, worm infections become less prevalent not only for them, but also for household contacts who reside in the same environment as treated children [56, 57]. Thus, this might explain the small effect size observed between children not receiving deworming treatment being anaemic compared to those who did receive deworming treatment.

We also found that the age of the respondents had a significant impact on the recipient of DM among children aged 6–59 months. Studies on the use of maternal and child health care services in general have reported poor outcomes among young women in SSA [58, 59]. For instance, adolescent girls and young women were less likely to use antenatal care (ANC) than older women [60]. Another study in Nigeria suggested that only a quarter of adolescent women received safe delivery care that was handled by skilled attendants [61, 62]. Additionally, utilization of postnatal care (PNC) was also unsatisfactory, with only a third of adolescent mothers receiving the service in SSA [62]. The reasons leading to such behaviour are often cited as lack of child-bearing experience [63, 64]. Thus, women with such poor health-seeking behaviours may be more likely to default to other important health services such as DM.

We found that children whose respondents had no formal education and resided in the poorest households were less likely to receive DM. The results are consistent with previous studies in resource-limited settings [65,66,67]. These results imply that women who have better education are more likely to comprehend the new knowledge and are more likely to know where to get care for their children. Additionally, education may empower women to have greater confidence, change of poor attitude, and capability of making a decision to use modern health services for themselves and for their children, including DM [68]. Previous studies have reported that higher income may be associated with a higher prospect to acquire improved health knowledge and health-seeking behaviour [69, 70], including DM. More importantly, wealthier households might be more likely to purchase or obtain DM [71].

We used data from samples that were nationally representative in all the included countries; therefore, our results may be generalized to the selected countries that were included in this study. The analysis controlled for a wide range of covariates, thereby strengthening the observed associations. We are aware of the potential limitations of the study. The findings cannot strictly be treated as causal due to the cross-sectional nature of the study designs. Given the nature of the variables, there is a potential for identification problems which may result in endogeneity [72]. Therefore, future research should aim at adopting quasi-experimental methods to address this issue [73].

Conclusions

The current study revealed empirical evidence of increased anaemia among children who had not received DM. Thus, targeted public health strategies that are aimed at reducing anaemia in pre-SAC should also consider population-based interventions such as DM. Further, in order to increase the uptake and coverage of DM, which eventually may improve Hb concentration of pre-SAC, socio-economically disadvantaged women should be targeted. However, longitudinal research is needed in order to validate the association that has been revealed in this current study. These results have policy implications in the sense that the WHO focus on DM could be extended to pre-SAC, a group most likely to be missed by interventions.

Availability of data and materials

The datasets generated and/or analysed during the present study are available in the DHS Program repository. https://dhsprogram.com/data/dataset/Malawi_Standard-DHS_2015.cfm?flag=1

Abbreviations

ANC:

Antenatal care

aOR:

Adjusted odds ratio

CDC:

Centers for Disease Control and Prevention

CI:

Confidence intervals

DHSs:

Demographic and health surveys

DM:

Deworming medication

Hb:

Haemoglobin

IRB:

Institutional review board

JMP:

Joint Monitoring Programme

NTDs:

Neglected tropical diseases

Pre-SAC:

Preschool-age children

SAC:

School-age children

SSA:

Sub-Saharan Africa

STH:

Soil-transmitted helminth

UNICEF:

United Nations Children’s Fund

WHO:

World Health Organization

References

  1. 1.

    World Health Organization (WHO). Soil-transmitted helminth infections. Geneva: WHO; 2020. https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections#:~:text=Soil-transmitted helminth infections are among the most common infections, areas where sanitation is poor. Accessed 27 Jan 2020.

  2. 2.

    Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521–32.

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    World Health Organization (WHO). Neglected tropical diseases. Geneva: WHO; 2017. https://www.who.int/neglected_diseases/news/WHO_publishes_recommendations_for_large-scale_deworming/en/. Accessed 28 Jan 2021.

  4. 4.

    World Health Organization (WHO). Deworming to combat the health and nutritional impact of soil-transmitted helminths. Geneva: WHO; 2012.

    Google Scholar 

  5. 5.

    World Health Organization (WHO). Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups. Geneva: WHO; 2017. http://www.who.int/elena/titles/full_recommendations/deworming/en/. Accessed 28 Jan 2021.

  6. 6.

    World Health Organization (WHO). Deworming in children. Geneva: WHO; 2019. https://www.who.int/elena/titles/deworming/en/. Accessed 28 Jan 2021.

  7. 7.

    Savioli L, Daumiere D, Savioli DD. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Geneva: World Health Organization; 2012. p. 42.

    Google Scholar 

  8. 8.

    World Health Organization (WHO). 2030 targets for soil-transmitted helminthiases control programmes. Geneva: World Health Organization; 2019.

    Google Scholar 

  9. 9.

    Montresor A, Trouleau W, Mupfasoni D, Bangert M, Joseph SA, Mikhailov A, et al. Preventive chemotherapy to control soil-transmitted helminthiasis averted more than 500 000 DALYs in 2015. Trans R Soc Trop Med Hyg. 2017;111:457–63.

    CAS  PubMed  Google Scholar 

  10. 10.

    Freeman MC, Akogun O, Belizario V Jr, Brooker SJ, Gyorkos TW, Imtiaz R, et al. Challenges and opportunities for control and elimination of soil-transmitted helminth infection beyond 2020. PLoS Negl Trop Dis. 2019;13: e0007201.

    PubMed  PubMed Central  Google Scholar 

  11. 11.

    World Health Organization (WHO). Soil-transmitted helminthiases: eliminating as public health problem soil-transmitted helminthiases in children: progress report 2001–2010 and strategic plan 2011–2020; 2012.

  12. 12.

    World Health Organization (WHO). WHO recommends large-scale deworming to improve children’s health and nutrition. Geneva: WHO; 2017. https://www.who.int/news/item/29-09-2017-who-recommends-large-scale-deworming-to-improve-children-s-health-and-nutrition. Accessed 28 Jan 2021.

  13. 13.

    Solomons NW. Pathways to the impairment of human nutritional status by gastrointestinal pathogens. Parasitology. 1993;107:S19–35.

    PubMed  Google Scholar 

  14. 14.

    Curtale F, Pokhrel RP, Tilden RL, Higashi G. Intestinal helminths and xerophthalmia in Nepal. A case–control study. J Trop Pediatr. 1995;41:334–7.

    CAS  PubMed  Google Scholar 

  15. 15.

    Callender JE, Walker SP, Grantham-McGregor SM, Cooper ES. Growth and development four years after treatment for the Trichuris dysentery syndrome. Acta Paediatr. 1998;87:1247–9.

    CAS  PubMed  Google Scholar 

  16. 16.

    Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low-and middle-income countries. Ann N Y Acad Sci. 2019;1450:15.

    PubMed  PubMed Central  Google Scholar 

  17. 17.

    World Health Organization (WHO). Global anaemia prevalence and number of individuals affected. Vitamin and mineral nutrition information system (VMNIS). Geneva. http://www.who.int/vmnis/anaemia/prevalence/summary/anaemia_data_status_t2/en/.

  18. 18.

    WHO/CDC. Worldwide prevalence of anaemia 1993–2005 WHO global database on anaemia. Geneva: WHO Press; 2005. p. 51.

    Google Scholar 

  19. 19.

    World Health Organization (WHO). Anaemia. Geneva: WHO; 2021. https://www.who.int/health-topics/anaemia#tab=tab_1. Accessed 20 Feb 2021.

  20. 20.

    Horton S, Ross J. The economics of iron deficiency. Food Policy. 2003;28:51–75.

    Google Scholar 

  21. 21.

    Luo D, Xu R, Ma J, Yan X, Hu P, Song Y, et al. The associations of economic growth and anaemia for school-aged children in China. Matern Child Nutr. 2020;16:e12936.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Calis JCJ, Phiri KS, Faragher EB, Brabin BJ, Bates I, Cuevas LE, et al. Severe anemia in Malawian children. N Engl J Med. 2008;358:888–99.

    CAS  PubMed  Google Scholar 

  23. 23.

    Oliveira D, Ferreira FS, Atouguia J, Fortes F, Guerra A, Centeno-Lima S. Infection by intestinal parasites, stunting and anemia in school-aged children from southern Angola. PLoS ONE. 2015;10:e0137327.

    PubMed  PubMed Central  Google Scholar 

  24. 24.

    Pullan RL, Gitonga C, Mwandawiro C, Snow RW, Brooker SJ. Estimating the relative contribution of parasitic infections and nutrition for anaemia among school-aged children in Kenya: a subnational geostatistical analysis. BMJ Open. 2013;3:e001936.

    PubMed  PubMed Central  Google Scholar 

  25. 25.

    Curtate F, Nabil M, El Wakeel A, Shamy MY. Anaemia and intestinal parasitic infections among school age children in Behera Governorate. Egypt J Trop Pediatr. 1998;44:323–8.

    Google Scholar 

  26. 26.

    Taylor-Robinson DC, Maayan N, Donegan S, Chaplin M, Garner P. Public health deworming programmes for soil-transmitted helminths in children living in endemic areas. Cochrane Database Syst Rev. 2019. https://doi.org/10.1002/14651858.CD000371.pub7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Welch VA, Ghogomu E, Hossain A, Awasthi S, Bhutta ZA, Cumberbatch C, et al. Mass deworming to improve developmental health and wellbeing of children in low-income and middle-income countries: a systematic review and network meta-analysis. Lancet Glob Health. 2017;5:e40–50.

    PubMed  Google Scholar 

  28. 28.

    Welch VA, Ghogomu E, Hossain A, Riddle A, Gaffey M, Arora P, et al. Mass deworming for improving health and cognition of children in endemic helminth areas: a systematic review and individual participant data network meta-analysis. Campbell Syst Rev. 2019;14:1–46.

    Google Scholar 

  29. 29.

    Girum T, Wasie A. The effect of deworming school children on anemia prevalence: a systematic review and meta-analysis. Open Nurs J. 2018;12:155.

    PubMed  PubMed Central  Google Scholar 

  30. 30.

    African Union Commission (AUC). Agenda 2063—the Africa we want. 2015.

  31. 31.

    United Nations Development Programme (UNDP). Sustainable development goals 2030. United Nations 2015. file:///C:/Users/PeterNtenda/Downloads/SDGs_Booklet_Web_En.pdf. Accessed 12 Feb 2021.

  32. 32.

    The DHS Program. Who we are. Meas DHS+, ORC Macro.

  33. 33.

    The DHS Program. Data > available datasets. Meas DHS. https://dhsprogram.com/data/available-datasets.cfm. Accessed 6 June 2019.

  34. 34.

    Assaf S, Kothari MT, Pullum TW. An assessment of the quality of DHS anthropometric data, 2005–2014. 4. DHS methodological reports no. 16. Rockville: ICF International; 2015.

  35. 35.

    The DHS Program. Methodology > biomarkers. Meas DHS. https://www.dhsprogram.com/Methodology/Biomarkers.cfm. Accessed 14 Feb 2021.

  36. 36.

    Chan M, World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: World Health Organization; 2011. p. 1–6.

    Google Scholar 

  37. 37.

    Lo NC, Snyder J, Addiss DG, Heft-Neal S, Andrews JR, Bendavid E. Deworming in pre-school age children: a global empirical analysis of health outcomes. PLoS Negl Trop Dis. 2018;12:e0006500.

    PubMed  PubMed Central  Google Scholar 

  38. 38.

    World Health Organization (WHO), United Nations Children’s Fund (UNICEF). Diarrhoea: why children are still dying and what can be done. 2009.

  39. 39.

    WHO Multicentre Growth Reference Study Group. WHO child growth standards: length/height-for-age, weight-forage, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.

    Google Scholar 

  40. 40.

    World Health Organization (WHO), United Nations Children’s Fund (UNICEF). WHO and UNICEF joint monitoring programme (JMP) for water supply and sanitation: types of drinking-water sources and sanitation. Geneva, Switzerland. http://www.wssinfo.org/definitions-methods/watsan-categories/. Accessed 8 Jan 2021.

  41. 41.

    Rutstein SO and KJ. The DHS wealth index. DHS comparative reports no. 6. Calverton: ORC Macro. 2004.

  42. 42.

    The World Bank Group. Prevalence of anemia among children (% of children under 5). 2021.

  43. 43.

    Stoltzfus RJ, Albonico M, Chwaya HM, Tielsch JM, Schulze KJ, Savioli L. Effects of the Zanzibar school-based deworming program on iron status of children. Am J Clin Nutr. 1998;68:179–86.

    CAS  PubMed  Google Scholar 

  44. 44.

    Trowbridge F, Martorell R. Forging effective strategies to combat iron deficiency. J Nutr. 2002;132:875S-879S.

    CAS  PubMed  Google Scholar 

  45. 45.

    Molla E, Mamo H. Soil-transmitted helminth infections, anemia and undernutrition among schoolchildren in Yirgacheffee, South Ethiopia. BMC Res Notes. 2018;11:585.

    PubMed  PubMed Central  Google Scholar 

  46. 46.

    Muñoz-Antoli C, Pérez P, Pavón A, Toledo R, Esteban J-G. Soil-transmitted helminth infections and anemia in schoolchildren from Corn Island Archipelago (RAAS, Nicaragua). Am J Trop Med Hyg. 2018;99:1591–7.

    PubMed  PubMed Central  Google Scholar 

  47. 47.

    Kumar S, Singh J, Kumar A. Prevalence and correlation of soil transmitted helminth infection to the degree of anemia and nutritional status among pediatric patients of age group 6–14 years in Kishanganj, Bihar, India. Int J Contemp Pediatr. 2017;4:223–31.

    Google Scholar 

  48. 48.

    De Gier B, Nga TT, Winichagoon P, Dijkhuizen MA, Khan NC, Van De Bor M, et al. Species-specific associations between soil-transmitted helminths and micronutrients in Vietnamese schoolchildren. Am J Trop Med Hyg. 2016;95:77–82.

    PubMed  PubMed Central  Google Scholar 

  49. 49.

    Osazuwa F, Ayo OM, Imade P. A significant association between intestinal helminth infection and anaemia burden in children in rural communities of Edo state, Nigeria. N Am J Med Sci. 2011;3:30–4.

    PubMed  PubMed Central  Google Scholar 

  50. 50.

    World Health Organization (WHO). Deworming for health and development: report of the third global meeting of the partners for parasite control. Geneva: World Health Organization; 2005.

    Google Scholar 

  51. 51.

    Montresor A, Crompton DWT, Hall A, Bundy DA, Savioli L, World Health Organization. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. Geneva: World Health Organization; 1998.

    Google Scholar 

  52. 52.

    World Health Organization (WHO). Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006.

    Google Scholar 

  53. 53.

    Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123:615–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. 54.

    World Health Organization (WHO). School deworming at glace. Geneva: WHO; 2021. https://www.who.int/docs/default-source/ntds/soil-transmitted-helminthiases/school-deworming-at-a-glance-2003.pdf?sfvrsn=a93eff88_4. Accessed 10 Jan 2021.

  55. 55.

    Clarke NE, Ng-Nguyen D, Traub RJ, Clements ACA, Halton K, Anderson RM, et al. A cluster-randomised controlled trial comparing school and community-based deworming for soil transmitted helminth control in school-age children: the CoDe-STH trial protocol. BMC Infect Dis. 2019;19:1–10.

    Google Scholar 

  56. 56.

    Innovations for Poverty Action (IPA). The long-term indirect impacts of early childhood deworming. http://www.poverty-action.org/study/long-term-indirect-impacts-early-childhood-deworming. Accessed 11 Jan 2020.

  57. 57.

    Miguel E, Kremer M. Worms: identifying impacts on education and health in the presence of treatment externalities. Econometrica. 2004;72:159–217.

    Google Scholar 

  58. 58.

    Mekonnen T, Dune T, Perz J. Maternal health service utilisation of adolescent women in sub-Saharan Africa: a systematic scoping review. BMC Pregnancy Childbirth. 2019;19:1–6.

    Google Scholar 

  59. 59.

    Efendi F, Chen C-M, Kurniati A, Berliana SM. Determinants of utilization of antenatal care services among adolescent girls and young women in Indonesia. Women Health. 2017;57:614–29.

    PubMed  Google Scholar 

  60. 60.

    Magadi MA, Agwanda AO, Obare FO. A comparative analysis of the use of maternal health services between teenagers and older mothers in sub-Saharan Africa: evidence from demographic and health surveys (DHS). Soc Sci Med. 2007;64:1311–25.

    PubMed  Google Scholar 

  61. 61.

    Reynolds HW, Wong EL, Tucker H. Adolescents’ use of maternal and child health services in developing countries. Int Fam Plan Perspect. 2006;32:6–16.

    PubMed  Google Scholar 

  62. 62.

    Rai RK, Singh PK, Singh L. Utilization of maternal health care services among married adolescent women: insights from the Nigeria demographic and health survey, 2008. Women’s Health Issues. 2012;22:e407–14.

    PubMed  Google Scholar 

  63. 63.

    Baral YR, Lyons K, Skinner J, van Teijlingen ER. Maternal health services utilisation in Nepal: progress in the new millennium? Health Sci J. 2012;6:618.

    Google Scholar 

  64. 64.

    Simkhada B, van Teijlingen ER, Porter M, Simkhada P. Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008;61:244–60.

    PubMed  Google Scholar 

  65. 65.

    Chakraborty N, Islam MA, Chowdhury RI, Bari W, Akhter HH. Determinants of the use of maternal health services in rural Bangladesh. Health Promot Int. 2003;18:327–37.

    PubMed  Google Scholar 

  66. 66.

    Kamal SMM. Factors affecting utilization of skilled maternity care services among married adolescents in Bangladesh. Asian Popul Stud. 2009;5:153–70.

    Google Scholar 

  67. 67.

    Munsur AM, Atia A, Kawahara K. Relationship between educational attainment and maternal health careutilization in Bangladesh: evidence from the 2005 Bangladesh household income and expenditure survey. Res J Med Sci. 2010;4:33–7.

    Google Scholar 

  68. 68.

    Nuamah GB, Agyei-Baffour P, Mensah KA, Boateng D, Quansah DY, Dobin D, et al. Access and utilization of maternal healthcare in a rural district in the forest belt of Ghana. BMC Pregnancy Childbirth. 2019;19:6.

    PubMed  PubMed Central  Google Scholar 

  69. 69.

    Ntenda PAM. Factors associated with non- and under-vaccination among children aged 12–23 months in Malawi. A multinomial analysis of the population-based sample. Pediatr Neonatol. 2019;60:623–33.

    PubMed  Google Scholar 

  70. 70.

    Abadura SA, Lerebo WT, Kulkarni U, Mekonnen ZA. Individual and community level determinants of childhood full immunization in Ethiopia: a multilevel analysis. BMC Public Health. 2015;15:972.

    PubMed  PubMed Central  Google Scholar 

  71. 71.

    Lo NC, Heft-Neal S, Coulibaly JT, Leonard L, Bendavid E, Addiss DG. State of deworming coverage and equity in low-income and middle-income countries using household health surveys: a spatiotemporal cross-sectional study. Lancet Glob Heal. 2019;7:e1511–20.

    Google Scholar 

  72. 72.

    Angrist JD, Pischke J-S. Mostly harmless econometrics: an empiricist’s companion. Princeton: Princeton University Press; 2008.

    Google Scholar 

  73. 73.

    Maciejewski ML. Quasi-experimental design. Biostat Epidemiol. 2020;4:38–47.

    Google Scholar 

  74. 74.

    The DHS Program. Protecting the privacy of DHS survey respondents. Meas DHS+, ORC Macro. https://dhsprogram.com/Methodology/Protecting-the-Privacy-of-DHS-Survey-Respondents.cfm. Accessed 19 Sept 2021.

Download references

Acknowledgements

We are sincerely grateful to the Monitoring and Evaluation to Assess and Use Results (MEASURE) Demographic and Health Surveys for allowing us to analyse the population-based datasets, that can be accessed through their archives repository (http://dhsprogram.com/data/available-datasets.cfm).

Funding

None.

Author information

Affiliations

Authors

Contributions

All authors contributed to the conception and design of the study. PAMN acquired the data and conducted the analysis. AB, ON, TEM, and SG interpreted the results. PAMN, ON, FNT, and GCC drafted the first manuscript. MGC, TEM, SG, and AB revised the draft for important intellectual content. All authors reviewed the final version of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Peter A. M. Ntenda.

Ethics declarations

Ethics approval and consent to participate

The DHS protocols and procedures were reviewed and approved by the institutional review board (IRB) in each of the host countries and the IRB of ICF Macro, and the Centers for Disease Control and Prevention (CDC) in Atlanta, GA, USA. Prior to the interviews and blood sample collection, all participants provided written informed consent. Permission was granted by the DHS Program for the use of the data. An IRB of ICF Macro ensured that the surveys were implemented in line with the US Department of Health and Human Services regulations for the protection of human subjects—Code of Federal Regulations Title 45: Public Welfare, part 46 (45 CFR 46) [74], while the host country IRB ensured that the survey was executed in line with the local laws and norms.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bauleni, A., Tiruneh, F.N., Mwenyenkulu, T.E. et al. Effects of deworming medication on anaemia among children aged 6–59 months in sub-Saharan Africa. Parasites Vectors 15, 7 (2022). https://doi.org/10.1186/s13071-021-05123-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-021-05123-4

Keywords

  • Coverage
  • Deworming medication
  • Anaemia
  • Haemoglobin
  • Sub-Saharan Africa